Clinical Research. Bioequivalence Studies. Biosciences.
Three disciplines. One Trusted Partner.
MARC brings scientific expertise, clinical capabilities, advanced laboratories, and regulatory knowledge together to support healthcare organizations from research to evidence.
EDA Licensed
Bioequivalence Center
GCP Certified
EDA & GCC Authorities
GLP Certified
EDA & GCC Authorities
Est. 2022
Egyptian Ministry of Health
From feasibility to final report — clinical, analytical, and molecular expertise working as one.
01
MARC-CROClinical research services designed to support studies from feasibility and start-up through execution, data, safety, and reporting.
● Medical Affairs & Medical Writing
● Clinical Operations
● Regulatory & Safety
● Biostatistics & Consultancy
02
MARC-BEEnd-to-end bioequivalence studies combining clinical operations, advanced bioanalysis, pharmacokinetics, and regulatory compliance.
● 64-Bed Clinical Unit
● HPLC / LC-MS / LC-MS/MS
● Complex Products (LAI, Transdermal)
● GCP & GLP Certified
03
MARC BIOLABSAdvanced laboratory capabilities spanning molecular biology, genomics, immunology, microbiology, preclinical research, nanotechnology, and biorepository services.
● NGS & Genomic Sequencing
● Cell-Based Assays
● Immunology Studies
● Biorepository & Sample Management
Founded & Registered
Our goal is to help bridge the gap between science and society by enabling research that improves health, strengthens healthcare systems, and elevates quality of life.
Through a multidisciplinary environment and collaborative partnerships, MARC supports investigators, research groups, and institutions in generating evidence that can translate into real-world healthcare solutions.
PURPOSE
To save and improve lives by translating research into accessible healthcare solutions.
MISSION
Address unmet medical needs through translational research and clinical innovation.
Advanced equipment and laboratory infrastructure designed to support the full research continuum.
Bed Clinical Unit
ICU · Emergency Pharmacy · Nurse Call System
Genomics Platform
Illumina MiSeq · NextSeq 2000
Advanced Bioanalysis
HPLC · LC-MS · LC-MS/MS
Sequencing Capabilities
WGS · RNA-seq · Metagenomics
MARC-BE combines Virtual Bioequivalence, PK/PD modeling, and simulation to help teams evaluate development scenarios before entering the clinic.
In collaboration with Expert Consult Ltd., we turn available data into predictive insights—helping optimize study design, reduce uncertainty, and support better R&D decisions.
“Model first. Test with greater confidence.”
From early planning through study execution and final reporting, MARC provides the specialized expertise and operational support required at each stage.
